MS

Manisha Singh

Director Director DIN 09356154
DIN 09356154 First appointment Oct 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2021
Shareholding value •••• Premium profile

About Manisha Singh

Data last updated:

Manisha Singh was a Director at Vikentiz Biolife Science Private Limited (2023–2025) and Additional Director at Maxelder Pharma Private Limited (2021–2022). The companies operate in Trading and Pharma.

DIN 09356154
Primary Designation Director
Industry Trading
First Appointment 13 Oct 2021

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 May 20232022₹76.2 Lakh (FY 2024)Active
Maxelder Pharma Private Limited U51909UP2020PTC134028
Additional Director13 Oct 20212020₹6.41 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vikentiz Biolife Science Private Limited
Maxelder Pharma Private Limited
Premium access

Shareholding and investment profile for Manisha Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manisha Singh

Manisha Singh was first appointed on 13 Oct 2021 as Additional Director at Maxelder Pharma Private Limited. The most recent appointment on record is 10 May 2023 at Vikentiz Biolife Science Private Limited.

Manisha Singh held 2 earlier board appointments: Vikentiz Biolife Science Private Limited (Director, 10 May 2023 to 12 Feb 2025); Maxelder Pharma Private Limited (Additional Director, 13 Oct 2021 to 01 Jan 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available